Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
329.00    -5.00 (-1.50%)
Bid:
322.00
Ask:
336.00
Spread: 14.00 (4.348%)
Market Cap: £41.75m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

19 Jan 2010 07:00

RNS Number : 7493F
BrainJuicer Group PLC
19 January 2010
 



Press release 

19 January 2010

BrainJuicer Group PLC

("BrainJuicer" or "the Group" or "the Company")

Trading Update

Profitable growth

Leading international online market researcher, BrainJuicer Group PLC, today gives the following update on trading ahead of its Preliminary Results for the financial year ended 31 December 2009 which will be announced on 9 March 2010.

Highlights:

 

·;  
Results expected to be in line with market expectations; profitable growth continues despite difficult market conditions and significant investment in product development, operations and technology
·;
Revenue up around 26% to approximately £11.7 million (2008: £9.3 million)
·;
Operating profit up by more than 25% to over £1.6 million (2008: £1.29 million)
·;
Strong financial position with cash up to around £2.3 million at 31 December 2009 (30 June 2009: £1.2m) and no debt
·;
Innovative ‘Juicy’ products grew 65% to over 60% of turnover [2008: 46%]
·;
Working with 11 of the world’s top 20 buyers of market research [9 in 2008]
·;
Both new offices, Switzerland and Germany achieved profitability in their first 18 months

BrainJuicer's reputation for innovation grew further in 2009 with revenue from the Group's strategically important 'Juicy' products making significant gains and now accounting for over 60% of the Group's revenue (2008: 46%). These products are being sold to some of the world's largest buyers of market research. In 2009 the Company's clients included 11 of the world's top 20 buyers of market research, up from 9 in 2008, and revenue from these clients grew by over 70%. Client satisfaction remains high with repeat business at around 80%.

Revenue increase was driven by continued strong progress in the US, growing at around 60%, and by very encouraging contributions from the new offices in Switzerland and Germany. The Company's  UK business recovered after a slow start to the year (revenue for the full year was around 2% lower), and Dutch revenue grew about 10%. Overall the Group achieved approximately 26% revenue growth (21% on a constant currency basis).

Operating profit is up by more than 25whilst having at the same time invested more than ever before in developing and validating productsin back-office operations and in the Company's software  platform. We believe this investment will drive future growth.

The Group has reached an agreement to acquire High Level Research Inc., its Canadian licencee, for a nominal sum This will be managed as a regional office within our North American business.

John KearonCEO of BrainJuicer, commented: "To have grown so strongly in a year when spending on market research seems to have declined for the first time in 25 years is a tremendous achievement and testament to the attraction of our innovative 'Juicy' products, expanded geographic footprint and talented researchers to our major multinational client base. Despite the dire economic conditions, we have continued to make significant investments.  Whilst many of the largest research agencies have apparently declined and retrenched during 2009, we continued to invest heavily in new and existing 'Juicy' products, enhancing the efficiency and scalability of our technology platform and expanding our geographic footprint. These investments will, we believe, enable us to secure the global and regional mandates which we need to fulfil our longer term ambitions.

"The Board is confident that in 2010 we can continue to grow our business through  further product  innovation and increasing our market share with major multinational customers."

An analyst presentation, given by John KearonCEO, and James Geddes, CFO, will be held at 9.30am on 9 March 2010 at Abchurch's office, 16th Floor, 125 Old Broad StreetLondonEC2N 1AR.

- Ends -

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0) 20 7043 1000

John Kearon, Chief Executive Officer

john.kearon@brainjuicer.com

James Geddes, Chief Financial Officer

james.geddes@brainjuicer.com

Canaccord Adams

Tel: +44 (0) 20 7050 6500

Mark Williams / Henry Fitzgerald-O'Connor

www.canaccordadams.com

Media enquiries:

Abchurch Communications

Heather Salmond / Joanne Shears

Tel: +44 (0) 20 7398 7709

joanne.shears@abchurch-group.com

www.abchurch-group.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWOWRROAAAAR
Date   Source Headline
24th Mar 20101:22 pmRNSDirector/PDMR Shareholding
10th Mar 20103:11 pmRNSBlocklisting Interim Review
10th Mar 20103:05 pmRNS2009 Final Dividend
10th Mar 20107:38 amRNS2010 Interim Dividend
9th Mar 20107:00 amRNSFinal Results
1st Feb 20107:00 amRNSAlex Batchelor Appointed COO
19th Jan 20107:00 amRNSTrading Update
4th Jan 20102:10 pmRNSShare Dealings
22nd Sep 20097:00 amRNSInterim Dividend
22nd Sep 20097:00 amRNSInterim Results
1st Sep 20097:00 amRNSNotice of Results
8th Jul 200912:46 pmRNSShare Dealings
8th Jul 20097:00 amRNSTrading Statement
13th May 200910:20 amRNSResult of AGM
17th Apr 20097:00 amRNSNotice of AGM
16th Apr 20093:15 pmRNSFinal Dividend
2nd Apr 20097:00 amRNSTrading on Sharemark
19th Mar 20097:00 amRNSPreliminary Results
5th Feb 200910:35 amRNSBlocklisting Interim Review and TVR
19th Jan 20097:00 amRNSPre-Close Trading Statement
13th Jan 200910:41 amRNSDirector's Dealings
9th Jan 20092:18 pmRNSDirector's Dealings
9th Dec 20087:00 amRNSExercise of Share Options
25th Nov 20087:00 amRNSDirector/PDMR Shareholding
13th Nov 20087:00 amRNSChange of Adviser
8th Oct 20086:02 pmRNSChange of Adviser Name
5th Sep 20087:00 amRNSInterim Results
4th Aug 20081:08 pmRNSBlocklisting Interim Review
1st Jul 20087:00 amRNSPre-Close Trading Statement
16th Jun 20087:00 amRNSGlobal Expansion
21st May 20084:40 pmRNSResult of AGM
10th Mar 20087:01 amRNSFinal Results
29th Feb 20087:00 amRNSTotal Voting Rights
25th Feb 20087:01 amRNSBlock Listing
12th Feb 20087:00 amRNSNotice of Results
11th Feb 20087:01 amRNSGlobal strategy
15th Jan 20087:00 amRNSTrading update
28th Dec 20074:51 pmRNSDirectors Dealing error
28th Dec 200711:38 amRNSDirectors Dealings
30th Nov 20077:00 amRNSIssue of Equity & TVR
31st Oct 20077:01 amRNSTotal Voting Rights
12th Oct 20077:01 amRNSIssue of Equity
20th Sep 20077:02 amRNSIndustry Award Winner
14th Sep 20071:15 pmRNSDirector/PDMR Shareholding
13th Sep 20077:01 amRNSInterim Results
5th Sep 20075:44 pmRNSNon-Exec Chairman Appointment
5th Sep 20077:01 amRNSNon-Exec Chairman Appointment
4th Sep 20077:01 amRNSNotice of Results
15th Aug 20078:10 amRNSAIM 26 and NOMAD name change
11th Jun 20077:02 amRNSCreativity Test

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.